Mike Evers, Author at ORTHOWORLD

Smith+Nephew Q1 Performance Highlighted by Robotics and Trauma

The company grew in the low single digits in the first quarter of 2025 as it incrementally improves its performance.

May 02, 2025

The company's orthopedic sales grew in the low single digits in the first quarter as it attempts to improve its supply chain.

May 01, 2025

A look at how the market's 2024 finish, resurgent M&A volume and the potential impact of tariffs on the orthopedic industry.

Apr 22, 2025

One-time events and competitive pressures created a slower start to 2025 for J&J MedTech's orthopedic sales.

Apr 17, 2025

Smith+Nephew's 12-Point Plan is working and driving improved performance for the company. But is it working fast enough?

Apr 09, 2025

We expect healthy demand, more competitive pressure at the top of the market and a focus on creating optionality within tech portfolios.

Mar 11, 2025

Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity.

Mar 10, 2025

Selected comments from the leaders of top orthopedic companies as they reported fourth quarter 2024 earnings.

Mar 05, 2025

The company grew in the high single digits in 2024 as it made significant progress integrating its Lima acquisition.

Feb 28, 2025

The company grew nearly 27% in 2024 as its technology and procedural approach continued to compel surgeon adoption in the spine market.

Feb 28, 2025